ZJULLi003-A, LSYMYH7iPS

General

Cell Line

hPSCreg name ZJUi011-A
Cite as:
ZJUi011-A (RRID:CVCL_C0IL)
Alternative name(s)
ZJULLi003-A, LSYMYH7iPS
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ZJUi012-A
(ZJULLi004-A, ZYLMYBPC3iPS)
Donor diseases:
Hypertrophic cardiomyopathy
ICANi001-A-1
(CDGEN1.16.40.5)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-1
(Rep 28, Iso Co)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-2
(Bi-allelic mutant, Mut 103)
Donor diseases:
hypertrophic cardiomyopathy
CIRMi893-A
(CW30205)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi036-A
(SCVI248)
Donor diseases:
hypertrophic cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
CIRMi909-A
(CW30224)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi919-A
(CW30234)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi920-A
(CW30235)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi609-A
(HPSI0516i-suqd_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi937-A
(CW30256)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi035-A
(NP0139-A, NP0139-3E)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi947-A
(CW30266)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-C
(NP0139-C, NP0139-24D)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi679-B
(HPSI0316i-ponl_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi685-B
(HPSI0416i-ioys_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi493-B
(HPSI0416i-ruah_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi508-B
(HPSI0416i-jewl_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi466-B
(HPSI0416i-aicq_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi483-B
(HPSI0416i-ourj_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi969-A
(CW30292)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi970-A
(CW30293)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi971-A
(CW30295)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi460-B
(HPSI0516i-jepf_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi609-B
(HPSI0516i-suqd_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi005-A
(F81 (940) clone 5)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-B
(F81 (940) clone 8)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi982-A
(CW30310)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi983-A
(CW30311)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi984-A
(CW30312)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi985-A
(CW30314)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi096-A
(SCVI-675fs1)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi097-A
(SCVI-675fs2)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi098-A
(SCVI-675fs3)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi099-A
(SCVI-675fs4)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi999-A
(CW30329)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00A-A
(CW30331)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi679-A
(HPSI0316i-ponl_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi746-A
(CW30024)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi484-B
(HPSI0716i-bakv_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi685-A
(HPSI0416i-ioys_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi00J-A
(CW30340)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi689-A
(HPSI0616i-newl_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi00M-A
(CW30344)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00N-A
(CW30345)
Donor diseases:
Hypertrophic Cardiomyopathy
Last update 3rd August 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Zhejiang University (ZJU)
Owner Zhejiang University Lianglab (ZJULL)
Distributors
Derivation country China

External Databases

BioSamples SAMEA14429757
Cellosaurus CVCL_C0IL
Wikidata Q112930593

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Ethnicity Chinese Han

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • HCM
  • Cardiomyopathy, hypertrophic
  • Enlarged and thickened heart muscle

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA14429758

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. jingjunzhou@zju.edu.cn
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Open Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Approval from the Sir Run Run Shaw Hospital Zhejiang University School of Medicine Review Board was obtained.
Approval number 20180601-010
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell line name Fibroblast
Derived from same source line (potentially other lot and donor, see below):
Source cell type
Synonyms
  • fibroblast
  • Fibroblasts
  • Fibroblast
  • FIBROBLAST
show more synonyms
Source cell origin
Synonyms
  • Skin zone

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR, Sequencing

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SOX2
Yes
SSEA-4
Yes
POU5F1 (OCT-4)
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
Mesoderm
Ont Id: UBERON_0000926
In vivo teratoma
Ectoderm
Ont Id: UBERON_0000924

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
003

Other Genotyping (Cell Line)